181 related articles for article (PubMed ID: 18839283)
1. Study of mesoporous silica/magnetite systems in drug controlled release.
Souza KC; Ardisson JD; Sousa EM
J Mater Sci Mater Med; 2009 Feb; 20(2):507-12. PubMed ID: 18839283
[TBL] [Abstract][Full Text] [Related]
2. Magnetic solid-phase extraction based on mesoporous silica-coated magnetic nanoparticles for analysis of oral antidiabetic drugs in human plasma.
de Souza KC; Andrade GF; Vasconcelos I; de Oliveira Viana IM; Fernandes C; de Sousa EM
Mater Sci Eng C Mater Biol Appl; 2014 Jul; 40():275-80. PubMed ID: 24857494
[TBL] [Abstract][Full Text] [Related]
3. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
4. Controlled drug delivery system based on ordered mesoporous silica matrices of captopril as angiotensin-converting enzyme inhibitor drug.
Popovici RF; Seftel EM; Mihai GD; Popovici E; Voicu VA
J Pharm Sci; 2011 Feb; 100(2):704-14. PubMed ID: 20740675
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous silica-magnetite nanocomposite synthesized by using a neutral surfactant.
Souza KC; Salazar-Alvarez G; Ardisson JD; Macedo WA; Sousa EM
Nanotechnology; 2008 May; 19(18):185603. PubMed ID: 21825691
[TBL] [Abstract][Full Text] [Related]
6. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect.
Al-Kady AS; Gaber M; Hussein MM; Ebeid el-ZM
Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 1D Fe₃O₄/P(MBAAm-co-MAA) nanochains as stabilizers for Ag nanoparticles and templates for hollow mesoporous structure, and their applications in catalytic reaction and drug delivery.
Zhang W; Si X; Liu B; Bian G; Qi Y; Yang X; Li C
J Colloid Interface Sci; 2015 Oct; 456():145-54. PubMed ID: 26119084
[TBL] [Abstract][Full Text] [Related]
8. Sonochemical coating of magnetite nanoparticles with silica.
Dang F; Enomoto N; Hojo J; Enpuku K
Ultrason Sonochem; 2010 Jan; 17(1):193-9. PubMed ID: 19502093
[TBL] [Abstract][Full Text] [Related]
9. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
[TBL] [Abstract][Full Text] [Related]
10. Formulation and In Vitro Characterization of Bioactive Mesoporous Silica with Doxorubicin and Metronidazole Intended for Bone Treatment and Regeneration.
Czarnobaj K; Prokopowicz M; Sawicki W
AAPS PharmSciTech; 2017 Nov; 18(8):3163-3171. PubMed ID: 28534298
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous silica-magnetite nanocomposite: fabrication and applications in magnetic bioseparations.
Sen T; Sebastianelli A; Bruce IJ
J Am Chem Soc; 2006 Jun; 128(22):7130-1. PubMed ID: 16734444
[TBL] [Abstract][Full Text] [Related]
12. Enantioselectively controlled release of chiral drug (metoprolol) using chiral mesoporous silica materials.
Guo Z; Du Y; Liu X; Ng SC; Chen Y; Yang Y
Nanotechnology; 2010 Apr; 21(16):165103. PubMed ID: 20351409
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of glycidyl methacrylate organo bridges grafted mesoporous silica SBA-15 as ibuprofen and mesalamine carrier for controlled release.
Rehman F; Rahim A; Airoldi C; Volpe PLO
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():970-979. PubMed ID: 26652455
[TBL] [Abstract][Full Text] [Related]
14. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
15. "Graft to" Synthesis and Ibuprofen-Loading Performance of pH-Sensitive PMAA-Silica Hybrid Nanoparticles with Controlled Bimodal Mesopores.
Han J; Sun J; Bai S; Panezai H; Jin X; Wu X
J Pharm Sci; 2015 Dec; 104(12):4299-4306. PubMed ID: 26501935
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro testing of thermoresponsive polymer-grafted core-shell magnetic mesoporous silica nanoparticles for efficient controlled and targeted drug delivery.
Peralta ME; Jadhav SA; Magnacca G; Scalarone D; Mártire DO; Parolo ME; Carlos L
J Colloid Interface Sci; 2019 May; 544():198-205. PubMed ID: 30844568
[TBL] [Abstract][Full Text] [Related]
17. Dual drug release from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats with distinct release profiles.
Song B; Wu C; Chang J
Acta Biomater; 2012 May; 8(5):1901-7. PubMed ID: 22326789
[TBL] [Abstract][Full Text] [Related]
18. An in situ synthesis of mesoporous SBA-16/hydroxyapatite for ciprofloxacin release: in vitro stability and cytocompatibility studies.
Andrade GF; Gomide VS; da Silva Júnior AC; Goes AM; de Sousa EM
J Mater Sci Mater Med; 2014 Nov; 25(11):2527-40. PubMed ID: 25056197
[TBL] [Abstract][Full Text] [Related]
19. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.
Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J
Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553
[TBL] [Abstract][Full Text] [Related]
20. Magnetic Field-Induced Accentuation of Drug Release from Core/Shell Magnetic Mesoporous Silica Nanoparticles for Anticancer Treatment.
Knezević Nikola Z
J Nanosci Nanotechnol; 2016 Apr; 16(4):4195-9. PubMed ID: 27451786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
